Background The RTS,S/AS01 malaria vaccine is currently being evaluated in a cluster-randomized pilot implementation programme in three African countries. This study seeks to identify whether vaccination could reach additional children who are at risk from malaria but do not currently have access to, or use, core malaria interventions. Methods Using data from household surveys, the overlap between malaria intervention coverage and childhood vaccination (diphtheria-tetanus-pertussis dose 3, DTP3) uptake in 20 African countries with at least one first administrative level unit with Plasmodium falciparum parasite prevalence greater than 10% was calculated. Multilevel logistic regression was used to explore patterns of overlap by demographic and...
Background: RTS,S/AS01 is the first vaccine against malaria to undergo pilot implementation, beginni...
BACKGROUND: RTS,S/AS01E is the lead candidate malaria vaccine. We recently showed efficacy against c...
BACKGROUND: The scaling of malaria control to achieve universal coverage requires a better understan...
Background The RTS,S/AS01 malaria vaccine is currently being piloted in three African countries. We ...
RTS,S/AS01 is a safe and moderately efficacious vaccine considered for implementation in endemic Afr...
The World Health Organization has selected Malawi as one of three sites to pilot the roll-out of RTS...
Background: The RTS,S/AS01 vaccine against P. falciparum malaria infection completed phase 3 trials ...
AbstractBackgroundRTS,S/AS01 is a safe and moderately efficacious vaccine considered for implementat...
BACKGROUND: The lack of background disease incidence rates in sub-Saharan countries where the RTS,S/...
<div><p>Background</p><p>A malaria vaccine could be an important addition to current control strateg...
BACKGROUND: GlaxoSmithKline Biologicals and the PATH Malaria Vaccine Initiative are working in partn...
RTS,S/AS01E malaria vaccine safety, effectiveness, and impact will be assessed in pre- and post-vacc...
The RTS,S/AS01 malaria vaccine candidate recently completed Phase III trials in 11 African sites. Re...
Malaria remains an important cause of morbidity and mortality among children in sub-Saharan Africa d...
BackgroundThe RTS,S/AS01 vaccine against Plasmodium falciparum malaria infection completed phase III...
Background: RTS,S/AS01 is the first vaccine against malaria to undergo pilot implementation, beginni...
BACKGROUND: RTS,S/AS01E is the lead candidate malaria vaccine. We recently showed efficacy against c...
BACKGROUND: The scaling of malaria control to achieve universal coverage requires a better understan...
Background The RTS,S/AS01 malaria vaccine is currently being piloted in three African countries. We ...
RTS,S/AS01 is a safe and moderately efficacious vaccine considered for implementation in endemic Afr...
The World Health Organization has selected Malawi as one of three sites to pilot the roll-out of RTS...
Background: The RTS,S/AS01 vaccine against P. falciparum malaria infection completed phase 3 trials ...
AbstractBackgroundRTS,S/AS01 is a safe and moderately efficacious vaccine considered for implementat...
BACKGROUND: The lack of background disease incidence rates in sub-Saharan countries where the RTS,S/...
<div><p>Background</p><p>A malaria vaccine could be an important addition to current control strateg...
BACKGROUND: GlaxoSmithKline Biologicals and the PATH Malaria Vaccine Initiative are working in partn...
RTS,S/AS01E malaria vaccine safety, effectiveness, and impact will be assessed in pre- and post-vacc...
The RTS,S/AS01 malaria vaccine candidate recently completed Phase III trials in 11 African sites. Re...
Malaria remains an important cause of morbidity and mortality among children in sub-Saharan Africa d...
BackgroundThe RTS,S/AS01 vaccine against Plasmodium falciparum malaria infection completed phase III...
Background: RTS,S/AS01 is the first vaccine against malaria to undergo pilot implementation, beginni...
BACKGROUND: RTS,S/AS01E is the lead candidate malaria vaccine. We recently showed efficacy against c...
BACKGROUND: The scaling of malaria control to achieve universal coverage requires a better understan...